A combination of softening demand for COVID vaccines overall and lingering safety concerns about the J&J shot, which was linked to extremely rare blood clots, left nearly half of the 21 million doses the company produced for the U.S. sitting unused, Reuters reported.
FDA extends shelf life of Johnson & Johnson COVID-19 vaccine by 50% as unused doses near expiration
Prepare Now Before its too Late
Discover where products are available & compare prices
